Cargando...

Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma

INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Lymphoma Myeloma Leuk
Main Authors: Mian, Hira, Fiala, Mark, Wildes, Tanya M
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/
https://ncbi.nlm.nih.gov/pubmed/31843543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!